Trial · NCT01769365

Concomitant, Sequential, and Standard Triple Therapy for H. Pylori Infection

NCT01769365, Phase 4, Completed, Kaohsiung Veterans General Hospital.; results first posted 2015-10-06

3 sourcestrials-2026-11-12-0.5.0

Cite this record

ConductScience Library. Concomitant, Sequential, and Standard Triple Therapy for H. Pylori Infection. Trials, record NCT01769365. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01769365

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title: Concomitant, Sequential, and Standard Triple Therapy for H. Pylori Infection
NCT number: NCT01769365
Status: Completed
Phases: Phase 4
Enrollment: 307 participants, actual
Lead sponsor: Kaohsiung Veterans General Hospital.
Conditions: Helicobacter Pylori Infection
Interventions: 7-day quadruple therapy, 10-day sequential therapy, 7-day standard triple therapy
First posted: 2013-01-16
Last updated: 2017-11-17
Results first posted: 2015-10-06
Limitations and caveats: The trial was performed in a single country

Source ClinicalTrials.gov

Registered outcomes1

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

List	Outcome	Time frame	Description
Primary	Number of Participants With Complete Eradication of Helicobacter Pylori	at the 6th week after the end of anti- H. pylori therapy	Evaluate eradication outcome by endoscopy urease test and histology or urea breath test

Source ClinicalTrials.gov

Outcomes1

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

Type	Outcome	Time frame	Population	Units	Measured as
PRIMARY	Number of Participants With Complete Eradication of Helicobacter Pylori	at the 6th week after the end of anti- H. pylori therapy		participants	NUMBER

Source ClinicalTrials.gov

Results by group3

Each measurement the trial posted, group by group, in the words and numbers it posted.

Outcome	Group	Value	Units
Number of Participants With Complete Eradication of Helicobacter Pylori	7-day Quadruple Therapy	102	participants
Number of Participants With Complete Eradication of Helicobacter Pylori	10-day Sequential Therapy	100	participants
Number of Participants With Complete Eradication of Helicobacter Pylori	7-day Standard Triple Therapy	101	participants

Source ClinicalTrials.gov

Participant flow9

How many started, completed or left each group, period by period.

Period	Milestone	Group	Participants
Overall Study	STARTED	7-day Quadruple Therapy	102
Overall Study	STARTED	10-day Sequential Therapy	102
Overall Study	STARTED	7-day Standard Triple Therapy	103
Overall Study	COMPLETED	7-day Quadruple Therapy	102
Overall Study	COMPLETED	10-day Sequential Therapy	100
Overall Study	COMPLETED	7-day Standard Triple Therapy	101
Overall Study	NOT COMPLETED	7-day Quadruple Therapy	0
Overall Study	NOT COMPLETED	10-day Sequential Therapy	2
Overall Study	NOT COMPLETED	7-day Standard Triple Therapy	2

Source ClinicalTrials.gov

Adverse events9

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

Type	Event	Organ system	Group	Affected	At risk	Events
other	Nausea	Gastrointestinal disorders	7-day Quadruple Therapy	7	102	7
other	Nausea	Gastrointestinal disorders	10-day Sequential Therapy	5	102	5
other	Nausea	Gastrointestinal disorders	7-day Standard Triple Therapy	3	103	3
other	Vomiting	Gastrointestinal disorders	7-day Quadruple Therapy	7	102	7
other	Vomiting	Gastrointestinal disorders	10-day Sequential Therapy	4	102	4
other	Vomiting	Gastrointestinal disorders	7-day Standard Triple Therapy	4	103	4
other	Diarrhea	Gastrointestinal disorders	7-day Quadruple Therapy	1	102	1
other	Diarrhea	Gastrointestinal disorders	10-day Sequential Therapy	0	102	0
other	Diarrhea	Gastrointestinal disorders	7-day Standard Triple Therapy	3	103	3

Source ClinicalTrials.gov

Adverse event totals9

The totals the trial posted for each group.

Total	Group	Affected	At risk
Total, all-cause mortality	7-day Quadruple Therapy
Total, all-cause mortality	10-day Sequential Therapy
Total, all-cause mortality	7-day Standard Triple Therapy
Total, other adverse events	7-day Quadruple Therapy	14	102
Total, other adverse events	10-day Sequential Therapy	9	102
Total, other adverse events	7-day Standard Triple Therapy	9	103
Total, serious adverse events	7-day Quadruple Therapy	0	102
Total, serious adverse events	10-day Sequential Therapy	0	102
Total, serious adverse events	7-day Standard Triple Therapy	0	103

Source ClinicalTrials.gov

Papers1

The papers the trial lists on ClinicalTrials.gov.

PMID	Listed as
25070099	DERIVED

Source PubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov: 2026-11-12; ClinicalTrials.gov
Results, from AACT: 2026-03-23; AACT
NIH grant links: 2026-11-13; NIH RePORTER

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT01769365

GET https://conductscience.org/api/trials/v1/NCT01769365/registered

API reference For AI assistants